Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual Meeting from October 20 to October 23, 2024. This event is a key gathering for professionals working in the fields of intellectual property, licensing, and technology transfer. This year’s meeting brought together more than 500 attendees from all corners of the globe.
The four-day conference showcased over 30 panel sessions and 15 roundtable discussions. The topics covered a wide range of issues, including utilizing the International Trade Commission for IP enforcement, branding, IP ownership in Life Sciences, Life Sciences spinouts, data usage in complex SEP licensing, the U.S. manufacturing requirement of the Bayh-Dole Act, utilizing Big Data for R&D improvements, negotiation strategies, common licensing pitfalls, content tailored for Emerging Leaders, career guidance for newcomers to the licensing field, and cutting-edge topics in AI, cross-industry partnerships, brand valuation trends, litigation finance, and the latest legal and legislative updates from both the U.S. and Europe.
Founded in 1965, the Licensing Executives Society (U.S.A. and Canada), Inc. (LES) is the largest of 32 global affiliated international societies under the umbrella of LES International (LESI). LES boasts a membership of over 1,600 professionals, while LESI has more than 6,500 members who are all dedicated to the creation, development, and transfer of intellectual property rights, as well as the protection, management, and standardization of intellectual capital.
Dear colleagues, we would like to inform you about the weekends and holidays in 2025…
Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting…
On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board…
The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the…
Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing…
Starting October 5, 2024, significant changes will take effect in Russia’s patent fee structure, following…